Expansion of TEER Indications: Acute Decompensated Heart Failure and Cardiogenic Shock
We Recommend
Disclosures
Within the last 24 months, I have financial relationship(s) or affiliation(s) with a manufacturer, marketer, reseller, or distributor of a healthcare product or service involved in the management of patients with any cardiovascular disease to include devices, drugs, and digital health care products listed below:
- Grant Support/Research Contract (Institutional) - Abbott Vascular; Medtronic; Boston Scientific Corporation; PulseCath BV; Daiichi-Sankyo/Elil Lilly and Company; Biotronik